Evidence map›Paper›PMID 41161804›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Hyperacute Guillain-Barré Syndrome Reaching Clinical Nadir Within 16 Hours.

Taiki Matsubayashi, Ryoko Muramatsu, Misako Furuki, Ayumi Uchibori, Masato Obayashi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Taiki MatsubayashiDepartment of Neurology, National Hospital Organization Disaster Medical Center, Japan.
Ryoko MuramatsuDepartment of Neurology, National Hospital Organization Disaster Medical Center, Japan.
Misako FurukiDepartment of Neurology, National Hospital Organization Disaster Medical Center, Japan.
Ayumi UchiboriDepartment of Neurology, Kyorin University, Japan.
Masato ObayashiDepartment of Neurology, National Hospital Organization Disaster Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 36-year-old man presented with rapidly progressive lower-limb weakness that reached its nadir within 16 h of the onset. The initial nerve conduction study (NCS) revealed no significant abnormalities except for a decrease in F-waves. Intravenous immunoglobulin therapy was administered, resulting in a gradual improvement in muscle strength. Follow-up NCS revealed findings consistent with axonal damage, and subsequent testing revealed positivity for immunoglobulin G-class anti-GM1 antibodies. The patient was finally diagnosed with acute motor axonal neuropathy, a variant of Guillain-Barré syndrome (GBS). This case highlights the importance of considering GBS even in patients with hyperacute progression to nadir within 24 h.

Indexed as

Guillain-Barre SyndromeAcute DiseaseAdultDisease ProgressionG(M1) GangliosideHumansImmunoglobulins, IntravenousMaleNerve Conduction StudiesNeural ConductionTime FactorsG(M1) GangliosideImmunoglobulins, Intravenousacute motor axonal neuropathyGuillain-Barré syndromehyperacute progression

Identifiers

PMID41161804
PMCPMC13349485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.